Next Article in Journal
Health Care, Health Caring, and the Culture of Medicine
Previous Article in Journal
Optimism About Breakthroughs in the Age of Targeted Therapy: the Canadian Lung Cancer Conference 2014; Vancouver, British Columbia; February 7, 2014
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 21
Issue 5
10.3747/co.21.2163
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Commentary

Hsp90 Inhibitors in Oncology: Ready for Prime Time?

by
S. Parimi
and
R.Y. Tsang
*
Department of Oncology, Division of Medical Oncology, University of Calgary, and Tom Baker Cancer Centre, Calgary, AB, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2014, 21(5), 663-667; https://doi.org/10.3747/co.21.2163
Submission received: 3 July 2014 / Revised: 5 August 2014 / Accepted: 10 September 2014 / Published: 1 October 2014

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In the targeted oncology era, there has been a resurgence of interest in targeting members of the heat shock protein family, as evidenced by numerous ongoing trials in advanced malignancies (Table I).[...]

Share and Cite

MDPI and ACS Style

Parimi, S.; Tsang, R.Y. Hsp90 Inhibitors in Oncology: Ready for Prime Time? Curr. Oncol. 2014, 21, 663-667. https://doi.org/10.3747/co.21.2163

AMA Style

Parimi S, Tsang RY. Hsp90 Inhibitors in Oncology: Ready for Prime Time? Current Oncology. 2014; 21(5):663-667. https://doi.org/10.3747/co.21.2163

Chicago/Turabian Style

Parimi, S., and R.Y. Tsang. 2014. "Hsp90 Inhibitors in Oncology: Ready for Prime Time?" Current Oncology 21, no. 5: 663-667. https://doi.org/10.3747/co.21.2163

APA Style

Parimi, S., & Tsang, R. Y. (2014). Hsp90 Inhibitors in Oncology: Ready for Prime Time? Current Oncology, 21(5), 663-667. https://doi.org/10.3747/co.21.2163

Article Metrics

Back to TopTop